Vancouver Prostate Centre scientists were the recipients of five of the twenty-six 2014 Movember Discovery Grants awarded by Prostate Cancer Canada on June 5, receiving three as principal investigators and two as co-investigators.
- Dr. Peter Black: Circulating tumour cells for risk stratification in men with localized prostate cancer
- Dr. Kim Chi: Genomic profiling of circulating tumour DNA (ctDNA) as a predictive biomarker for patients with castration resistant prostate cancer (CRPC)
- Dr. Yuzhuo Wang: Identification of genes involved in development and progression of neuroendocrine prostate cancer
- Dr. Juan Ausio, University of Victoria (Co-Investigator: Dr. Paul Rennie): Examining the interplay between H2A.Z and EZH2 in androgen receptor dependent and independent signalling in prostate cancer
- Dr. Gerald Krystal, British Columbia Cancer Agency (Co-Investigator: Dr. Paul Rennie):Generation of mesenchymal stromal cells infected with oncolytic herpes viruses expressing immune modulators to treat prostate cancer
Also announced on June 5, the 2014 Movember Team Grant was awarded to a team lead by a team lead by Dr. John Bartlett of the Ontario Institute for Cancer Research, Toronto, Ontario. Dr. Ralph Buttyan was one of twelve co-investigators on this grant, titled The prostate cancer program project in rapid development of novel diagnostic markers for early prostate cancer (PRONTO).
A full list of the funding decisions is available at the Prostate Cancer Canada website.